AWAngela White
Angela White
*This is an algorithmically generated author record based on publicly available information.
Research Subjects
Angela White has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
Melisa Masuda-Herrera
Gilead Sciences, Inc., Nonclinical Safety and Pathobiology, Foster City, CA, USA
2 shared publicationsMichelle Kenyon
Pfizer Global Research & Development, Groton, CT, USA
2 shared publicationsSusanne Glowienke
Novartis Pharma AG, Pre-Clinical Safety, Basel, Switzerland
2 shared publications- Ailis Maisey
GlaxoSmithKline R&D, Ware, Hertfordshire, UK
1 shared publication Alejandra Trejo-Martin
Gilead Sciences, Inc., Nonclinical Safety and Pathobiology, Foster City, CA, USA
1 shared publication- Andreas Czich
Sanofi, R&D Translational Medicine Preclinical Safety , Frankfurt D-69526
1 shared publication
Latest Publications
- 1 November 2021
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 126, 105023
Calculating qualified non-mutagenic impurity levels: Harmonization of approaches
- 1 November 2021
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 126, 105023
Calculating qualified non-mutagenic impurity levels: Harmonization of approaches
- 1 July 2021
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 123, 104926
Use of less-than-lifetime (LTL) durational limits for nitrosamines: Case study of N-Nitrosodiethylamine (NDEA)
- 1 July 2021
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 123, 104926
Use of less-than-lifetime (LTL) durational limits for nitrosamines: Case study of N-Nitrosodiethylamine (NDEA)